ALINITY I TOTAL B-HCG REAGENT KIT
Report
- Report Number
- 3005094123-2025-00541
- Event Type
- Malfunction
- Date Received
- October 28, 2025
- Date of Event
- October 14, 2025
- Report Date
- January 19, 2026
- Manufacturer
- ABBOTT IRELAND DIAGNOSTICS DIVISION
- Product Code
- DHA
- UDI-DI
- 00380740121501
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SW
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
DATA AND INFORMATION PROVIDED BY THE CUSTOMER WERE REVIEWED AND SUPPORT THE COMPLAINT ISSUE WITHOUT INDICATION FOR ANY ADDITIONAL ISSUE. A REVIEW OF TRACKING AND TRENDING DID IDENTIFY AN INCREASE IN COMPLAINT ACTIVITY. HOWEVER, NO COMMONALITIES FOR THE COMPLAINT LOT AND ISSUE WERE IDENTIFIED. DEVICE HISTORY RECORD REVIEW DID NOT IDENTIFY ANY NON-CONFORMANCES, POTENTIAL NON-CONFORMANCES OR DEVIATIONS ASSOCIATED WITH LOT 71455UD00 AND THE COMPLAINT ISSUE. IN-HOUSE ACCURACY TESTING OF A RETAINED KIT OF LOT 71455UD00 WAS COMPLETED. ALL SPECIFICATIONS WERE MET INDICATING THE LOT IS PERFORMING ACCEPTABLY. THE OVERALL PERFORMANCE OF THE ALINITY I TOTAL B-HCG REAGENTS IN THE FIELD WAS REVIEWED USING DATA GATHERED FROM CUSTOMERS WORLDWIDE. REVIEW SHOWS THAT THE MEDIAN PATIENT RESULT FOR THE LOT IS WITHIN ESTABLISHED LIMITS AND COMPARABLE WITH OTHER LOTS IN THE FIELD, CONFIRMING NO SYSTEMIC ISSUE FOR THE LOT. LABELING WAS REVIEWED AND WAS FOUND TO ADEQUATELY ADDRESS THE CURRENT ISSUE. BASED ON THE INVESTIGATION, NO SYSTEMIC ISSUE OR DEFICIENCY OF THE ALINITY I TOTAL B-HCG REAGENT LOT 71455UD00 WAS IDENTIFIED.
AN EVALUATION IS IN PROCESS. A FINAL REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. COMPLETED INFORMATION FOR SECTION A1 - PATIENT IDENTIFIER: SIDS (B)(6). ALL AVAILABLE PATIENT INFORMATION WAS INCLUDED. ADDITIONAL PATIENT DETAILS ARE NOT AVAILABLE. THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 7P51-30, THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 7P51-21/-31, WITH 510K/PMA/BLA NUMBER K170317.
THE CUSTOMER OBSERVED A DECREASED ALINITY I TOTAL -HCG RESULT FOR A 39-YEAR-OLD FEMALE PATIENT SAMPLE. THE FOLLOWING DATA WAS PROVIDED (INTERPRETATION OF RESULTS <5.00 MIU/ML IS NEGATIVE, >/=25.00 MIU/ML IS POSITIVE): ON (B)(6) 2025, SAMPLE ID (B)(6), RESULT = 392 IU/L, (B)(6) 2025, SAMPLE ID (B)(6), INITIAL RESULT = <2,300 MIU/ML, (B)(6) 2025, SAMPLE ID (B)(6), RESULT = <2.3 IU/L, (B)(6) 2025, PATIENT TESTED AT ANOTHER LABORATORY DUE TO A POSSIBLE MISCARRIAGE AND RESULT = 3593 IU/L, (B)(6) 2025, SAME SAMPLE WAS ANALYZED AFTER BEING FROZEN, THAWED, AND DILUTED. RESULT = ABOUT 2000 MIU/ML. ALL SAMPLE IDS ARE FOR THE SAME PATIENT. MIU/ML = IU/L. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.
THE CUSTOMER OBSERVED A DECREASED ALINITY I TOTAL -HCG RESULT FOR A 39-YEAR-OLD FEMALE PATIENT SAMPLE. THE FOLLOWING DATA WAS PROVIDED (INTERPRETATION OF RESULTS <5.00 MIU/ML IS NEGATIVE, >/=25.00 MIU/ML IS POSITIVE): (B)(6) 2025 SAMPLE ID (B)(6) RESULT = 392 IU/L. (B)(6) 2025 SAMPLE ID (B)(6) INITIAL RESULT = <2,300 MIU/ML. (B)(6) 2025 SAMPLE ID (B)(6) RESULT = <2.3 IU/L. (B)(6) 2025 PATIENT TESTED AT ANOTHER LABORATORY DUE TO A POSSIBLE MISCARRIAGE AND RESULT = 3593 IU/L. (B)(6) 2025 SAME SAMPLE WAS ANALYZED AFTER BEING FROZEN, THAWED, AND DILUTED. RESULT = ABOUT 2000 MIU/ML. ALL SAMPLE IDS ARE FOR THE SAME PATIENT. MIU/ML = IU/L. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2352077 | ALINITY I TOTAL B-HCG REAGENT KIT | SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN | DHA | ABBOTT IRELAND DIAGNOSTICS DIVISION | 71455UD00 | 00380740121501 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 39 YR | Female | ALNTY I PROCESSING MODU, 03R65-01, (B)(6) |